Inventor · disambiguated record
Henry C. Marsh, Jr.
Also filed as: MARSH HENRY · MARSH HENRY C · MARSH JR HENRY C · MARSH JR HENRY CLINTON
21 granted patents·5 pending applications·649 citations·filing 1988–2024
96Inventor score
Files withT CELL SCIENCES INC8CELLDEX THERAPEUTICS INC5UNIV JOHNS HOPKINS4AVANT IMMUNOTHERAPEUTICS INC2CELDARA MEDICAL LLC2
Top patents by PatentIndex Score
26 records- 0196US9169325B2Antibodies that bind human CD27 and uses thereofKELER TIBOR·Filed 2011·Granted Oct 27, 2015·64 cites·19 claims
- 0292US5456909AGlycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivoT CELL SCIENCES INC·Filed 1992·Granted Oct 10, 1995·92 cites·16 claims
- 0390US5472939AMethod of treating complement mediated disordersUNIV JOHNS HOPKINS·Filed 1993·Granted Dec 5, 1995·70 cites·37 claims
- 0489US5981481AHuman C3b/C4b receptor (CR1)UNIV JOHNS HOPKINS·Filed 1995·Granted Nov 9, 1999·80 cites·42 claims
- 0587US5858969ATherapeutic methods employing sialylated glycoforms of soluble complement receptor 1 (SCR 1)T CELL SCIENCES INC·Filed 1995·Granted Jan 12, 1999·72 cites·16 claims
- 0686US5856297AHuman C3b/C4b receptor (CR1)UNIV JOHNS HOPKINS·Filed 1995·Granted Jan 5, 1999·58 cites·14 claims
- 0786US5256642ACompositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereofUNIV JOHNS HOPKINS·Filed 1990·Granted Oct 26, 1993·49 cites·13 claims
- 0885US11180566B2Antibodies that bind human CD27 and uses thereofCELLDEX THERAPEUTICS INC·Filed 2015·Granted Nov 23, 2021·4 cites·7 claims
- 0984US6057131APreparation and use of sialylated glycoforms of soluble complement receptor 1 (CR1)AVANT IMMUNOTHERAPEUTICS INC·Filed 1998·Granted May 2, 2000·53 cites·28 claims
- 1081US5173499ACompounds which inhibit complement and/or suppress immune activityT CELL SCIENCES INC·Filed 1988·Granted Dec 22, 1992·14 cites·13 claims
- 1180US6316604B1Human C3b/C4b receptor (CR1)AVANT IMMUNOTHERAPEUTICS INC·Filed 1995·Granted Nov 13, 2001·46 cites·14 claims
- 1279US8664176B2Treatment for age-related macular degeneration and other diseases of the eyeMARSH HENRY C·Filed 2007·Granted Mar 4, 2014·5 cites·13 claims
- 1377US9649357B2Treatment of chronic nephropathies using soluble complement receptor type I (sCR1)CELLDEX THERAPEUTICS INC·Filed 2016·Granted May 16, 2017·2 cites·8 claims
- 1475US2025059291A1Cd27 agonistsCELLDEX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1572US11541076B2Chimeric antigen receptors targeting TIM-1CELDARA MEDICAL LLC·Filed 2018·Granted Jan 3, 2023·2 cites·20 claims
- 1670US5506247ACompounds that inhibit complement and/or suppress immune activityT CELL SCIENCES INC·Filed 1991·Granted Apr 9, 1996·11 cites·13 claims
- 1770US2022227877A1Antibodies that bind human cd27 and uses thereofCELLDEX THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1868US9295713B2Treatment of chronic nephropathies using soluble complement receptor type I (sCR1)SMITH RICHARD J H·Filed 2011·Granted Mar 29, 2016·2 cites·19 claims
- 1968US5808109ACompounds that inhibit complement and/or suppress immune activityT CELL SCIENCES INC·Filed 1995·Granted Sep 15, 1998·11 cites·3 claims
- 2067US5366986ACompounds which inhibit complement and/or suppress immune activityT CELL SCIENCES INC·Filed 1990·Granted Nov 22, 1994·9 cites·30 claims
- 2157US2023355673A1Chimeric antigen receptors targeting tim-1CELDARA MEDICAL LLC·Filed 2022·Application pending·0 cites
- 2250US5401767ACompounds which inhibit complement and/or suppress immune activityT CELL SCIENCES INC·Filed 1992·Granted Mar 28, 1995·3 cites·18 claims
- 2348US2018044429A1Cd27 agonistsCELLDEX THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2445US5656659ACompounds which inhibit complement and/or suppress immune activityT CELL SCIENCES INC·Filed 1994·Granted Aug 12, 1997·2 cites·8 claims
- 2544US9290946B1Methods and devices for aligning and coupling a roofing profile to a roofJOHNS MANVILLE·Filed 2014·Granted Mar 22, 2016·0 cites·19 claims
- 2641US2012213771A1Antibodies that bind human cd27 and uses thereofKELER TIBOR·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →